3tcp: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC569== | ==Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC569== | ||
<StructureSection load='3tcp' size='340' side='right' caption='[[3tcp]], [[Resolution|resolution]] 2.69Å' scene=''> | <StructureSection load='3tcp' size='340' side='right' caption='[[3tcp]], [[Resolution|resolution]] 2.69Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[3tcp]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/ | <table><tr><td colspan='2'>[[3tcp]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3TCP OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3TCP FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CKJ:1-[(TRANS-4-AMINOCYCLOHEXYL)METHYL]-N-BUTYL-3-(4-FLUOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-6-AMINE'>CKJ</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CKJ:1-[(TRANS-4-AMINOCYCLOHEXYL)METHYL]-N-BUTYL-3-(4-FLUOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-6-AMINE'>CKJ</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[3bpr|3bpr]], [[2brb|2brb]], [[2poc|2poc]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[3bpr|3bpr]], [[2brb|2brb]], [[2poc|2poc]]</td></tr> | ||
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">MERTK, MER ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">MERTK, MER ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> | ||
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Receptor_protein-tyrosine_kinase Receptor protein-tyrosine kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.10.1 2.7.10.1] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Receptor_protein-tyrosine_kinase Receptor protein-tyrosine kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.10.1 2.7.10.1] </span></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3tcp FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3tcp OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3tcp RCSB], [http://www.ebi.ac.uk/pdbsum/3tcp PDBsum]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3tcp FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3tcp OCA], [http://pdbe.org/3tcp PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3tcp RCSB], [http://www.ebi.ac.uk/pdbsum/3tcp PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=3tcp ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Disease == | == Disease == | ||
| Line 21: | Line 22: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
<div class="pdbe-citations 3tcp" style="background-color:#fffaf0;"></div> | |||
==See Also== | ==See Also== | ||
| Line 28: | Line 30: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: | [[Category: Human]] | ||
[[Category: Receptor protein-tyrosine kinase]] | [[Category: Receptor protein-tyrosine kinase]] | ||
[[Category: DeRyckere, D]] | [[Category: DeRyckere, D]] | ||
Revision as of 13:31, 11 August 2016
Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC569
| ||||||||||||
Proteopedia Page Contributors and Editors (what is this?)
Categories:
- Human
- Receptor protein-tyrosine kinase
- DeRyckere, D
- Deusen, A Van
- Earp, H S
- Frye, S
- Graham, D K
- Hunter, D
- Janzen, W P
- Johnson, G
- Kireev, D B
- Liu, J
- Machius, M
- Miley, M
- Norris-Drouin, J
- Patel, H S
- Sather, S
- Simpson, C
- Wang, X
- Yang, C
- Acute lymphoblastic leukemia
- Rational structure-based drug design
- Transferase-transferase inhibitor complex
- Tyrosine kinase